193 related articles for article (PubMed ID: 10227004)
1. Postmenopausal women without previous or current vasomotor symptoms do not flush after abruptly abandoning estrogen replacement therapy.
Hammar M; Ekblad S; Lönnberg B; Berg G; Lindgren R; Wyon Y
Maturitas; 1999 Jan; 31(2):117-22. PubMed ID: 10227004
[TBL] [Abstract][Full Text] [Related]
2. Vasomotor hot flushes and 24-hour ambulatory blood pressure in normotensive women: A placebo-controlled trial on post-menopausal hormone therapy.
Tuomikoski P; Haapalahti P; Sarna S; Ylikorkala O; Mikkola TS
Ann Med; 2010 Jul; 42(5):334-43. PubMed ID: 20429800
[TBL] [Abstract][Full Text] [Related]
3. Vasomotor hot flashes and heart rate variability: a placebo-controlled trial of postmenopausal hormone therapy.
Lantto H; Haapalahti P; Tuomikoski P; Viitasalo M; Väänänen H; Sovijärvi AR; Ylikorkala O; Mikkola TS
Menopause; 2012 Jan; 19(1):82-8. PubMed ID: 21934534
[TBL] [Abstract][Full Text] [Related]
4. Effects of estrogen therapy on well-being in postmenopausal women without vasomotor complaints.
Skarsgård C; E Berg G; Ekblad S; Wiklund I; Hammar ML
Maturitas; 2000 Aug; 36(2):123-30. PubMed ID: 11006499
[TBL] [Abstract][Full Text] [Related]
5. Relation between plasma hormone profiles, symptoms, and response to oestrogen treatment in women approaching the menopause.
Chakravarti S; Collins WP; Thom MH; Studd JW
Br Med J; 1979 Apr; 1(6169):983-5. PubMed ID: 219937
[TBL] [Abstract][Full Text] [Related]
6. A 17β-Estradiol-Progesterone Oral Capsule for Vasomotor Symptoms in Postmenopausal Women: A Randomized Controlled Trial.
Lobo RA; Archer DF; Kagan R; Kaunitz AM; Constantine GD; Pickar JH; Graham S; Bernick B; Mirkin S
Obstet Gynecol; 2018 Jul; 132(1):161-170. PubMed ID: 29889748
[TBL] [Abstract][Full Text] [Related]
7. Biological effects of hormone replacement therapy in relation to serum estradiol levels.
Yasui T; Uemura H; Tezuka M; Yamada M; Irahara M; Miura M; Aono T
Horm Res; 2001; 56(1-2):38-44. PubMed ID: 11815726
[TBL] [Abstract][Full Text] [Related]
8. Hormone replacement therapy for oxidative stress in postmenopausal women with hot flushes.
Leal M; Díaz J; Serrano E; Abellán J; Carbonell LF
Obstet Gynecol; 2000 Jun; 95(6 Pt 1):804-9. PubMed ID: 10831971
[TBL] [Abstract][Full Text] [Related]
9. Serum estrogen level after hormone replacement therapy and body mass index in postmenopausal and bilaterally ovariectomized women.
Yasui T; Uemura H; Umino Y; Takikawa M; Saito S; Kuwahara A; Matsuzaki T; Maegawa M; Furumoto H; Miura M; Irahara M
Maturitas; 2005 Jan; 50(1):19-29. PubMed ID: 15590210
[TBL] [Abstract][Full Text] [Related]
10. A short study in the treatment of hot flashes with buccal administration of 17-beta estradiol.
Gass MS; Rebar RW; Cuffie-Jackson C; Cedars MI; Lobo RA; Shoupe D; Judd HL; Buyalos RP; Clisham PR
Maturitas; 2004 Oct; 49(2):140-7. PubMed ID: 15474758
[TBL] [Abstract][Full Text] [Related]
11. Transition from estrogen-progestin to raloxifene in postmenopausal women: effect on vasomotor symptoms.
Gordon S; Walsh BW; Ciaccia AV; Siddhanti S; Rosen AS; Plouffe L
Obstet Gynecol; 2004 Feb; 103(2):267-73. PubMed ID: 14754694
[TBL] [Abstract][Full Text] [Related]
12. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the effects of oral conjugated equine estrogen and transdermal estradiol-17 beta combined with an oral progestin on quality of life in postmenopausal women.
Hilditch JR; Lewis J; Ross AH; Peter A; van Maris B; Franssen E; Charles J; Norton P; Dunn EV
Maturitas; 1996 Jul; 24(3):177-84. PubMed ID: 8844631
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of continuous combined hormone replacement therapy in early postmenopausal women.
Mattsson LA; Skouby S; Rees M; Heikkinen J; Kudela M; Stadnicki-Kolendo A; Mattila L; Salminen K; Vuorela A; Mustonen M;
Menopause Int; 2007 Sep; 13(3):124-31. PubMed ID: 17785038
[TBL] [Abstract][Full Text] [Related]
15. Effect of an estradiol gel with monthly or quarterly progestogen on menopausal symptoms and bleeding.
Hirvonen E; Crona N; Wahlström T; Bäckström AC
Climacteric; 2000 Dec; 3(4):262-70. PubMed ID: 11910586
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of a new, oral estradiol acetate formulation for relief of menopause symptoms.
Speroff L; Haney AF; Gilbert RD; Ellman H;
Menopause; 2006; 13(3):442-50. PubMed ID: 16735941
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous 17beta-estradiol gel for the treatment of vasomotor symptoms in postmenopausal women.
Archer DF;
Menopause; 2003; 10(6):516-21. PubMed ID: 14627859
[TBL] [Abstract][Full Text] [Related]
18. Estradiol 1 mg and drospirenone 2 mg as hormone replacement therapy in postmenopausal Chinese women.
Lin SQ; Sun LZ; Lin JF; Yang X; Zhang LJ; Qiao J; Wang ZH; Xu YX; Xiong ZA; Zhou YZ; Wang ML; Zhu J; Chen SR; Su H; Yang CS; Wang SH; Zhang YZ; Dong XJ
Climacteric; 2011 Aug; 14(4):472-81. PubMed ID: 21469973
[TBL] [Abstract][Full Text] [Related]
19. Effects of estrogen therapy on postmenopausal sleep quality regardless of vasomotor symptoms: a randomized trial.
Tansupswatdikul P; Chaikittisilpa S; Jaimchariyatam N; Panyakhamlerd K; Jaisamrarn U; Taechakraichana N
Climacteric; 2015 Apr; 18(2):198-204. PubMed ID: 25242569
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of continuous sequential transdermal estradiol and norethindrone acetate in relieving vasomotor symptoms associated with menopause.
Notelovitz M; Cassel D; Hille D; Furst KW; Dain MP; VandePol C; Skarinsky D
Am J Obstet Gynecol; 2000 Jan; 182(1 Pt 1):7-12. PubMed ID: 10649149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
